AorTech Biomaterials, pty is focused on the commercialization of its world leading biomedical polymer technology, components and medical devices. It is a wholly owned subsidiary of AorTech International, plc which is listed on the UK London Stock Exchanges, Alternative Investment Market (AIM: AOR).
AorTech Biomaterials is based in Australia, where its principal manufacturing and research and development facility is located.
AorTech Medical Devices, USA is located in Salt Lake City, UT. AMD serves as the sales and distribution arm for the Biomaterials Division and AMD operates a device development lab in Del Ray Beach, FL.The company employs approximately 40 people internationally.
AorTech’s technologies have been designed to improve the performance and reliability of existing medical devices provide medical device designers with advantages and design options that were not available prior to the commercialization of our high performance polymer technologies.
Our business model is based on licensing our polymer technology to medical device companies. We then work as a partner with the device company to assist with their development programs resulting in a cost effective and rapid move to device registration and revenues. As part of this model, AorTech supplies polymers and/or AorTech can manufacture components for the partner.